Ceftriaxone Sulbactam Ceforf-s 375

PRODUCT NAME : Ceforf-S 375

Dosage Form: Injection

Packing: Vial

Ceforf-S 375 by Biomorph Lifesciences is a combination of Ceftriaxone 250 mg and Sulbactam 125 mg, formulated to provide broad-spectrum antibacterial coverage against susceptible bacterial infections. Ceftriaxone is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Sulbactam is a beta-lactamase inhibitor that enhances the effectiveness of Ceftriaxone by protecting it from enzyme-mediated bacterial resistance. This combination helps deliver improved antibacterial activity against a wide range of susceptible microorganisms.

Ceforf-S 375 is intended for administration by qualified healthcare professionals and is commonly prescribed for the management of respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, bone and joint infections, gynecological infections, and other bacterial infections where this combination is clinically appropriate. The medicine should always be used under the guidance of a registered medical practitioner.

At Biomorph Lifesciences, Ceforf-S 375 is manufactured in WHO-GMP-compliant facilities using advanced manufacturing processes and stringent quality control standards. We offer this product for PCD Pharma Franchise and Third-Party Manufacturing across India, ensuring reliable quality, secure packaging, timely delivery, and consistent manufacturing support to help pharmaceutical businesses expand their product portfolio with confidence.

Category: Injection

Description

Description

MORE DETAILS ABOUT PRODUCT

Ceforf-S 375mg

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, resulting in effective bactericidal activity.
Sulbactam is a beta-lactamase inhibitor that protects Ceftriaxone from bacterial enzyme degradation, helping restore and enhance its antibacterial effectiveness.
Provides broad-spectrum activity against a wide range of Gram-positive and Gram-negative bacteria, including beta-lactamase-producing strains.
Commonly prescribed for the management of respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, gynecological infections, and other susceptible bacterial infections.
Suitable for intravenous (IV) or intramuscular (IM) administration under the supervision of a qualified healthcare professional.
Manufactured under WHO-GMP-compliant facilities with stringent quality control to ensure safety, purity, and consistent performance.

Indications

Key Benefits of Ceforf-S 375 (Ceftriaxone & Sulbactam for Injection)

Broad-Spectrum Antibacterial Coverage – Effective against a wide range of Gram-positive and Gram-negative bacteria.
Enhanced Antibacterial Action – Sulbactam inhibits beta-lactamase enzymes, helping restore and enhance the effectiveness of Ceftriaxone.
Rapid Bactericidal Activity – Works by inhibiting bacterial cell wall synthesis to help eliminate susceptible bacteria efficiently.
Effective Against Resistant Strains – Designed to combat beta-lactamase-producing bacteria that may reduce the effectiveness of antibiotics.
Versatile Clinical Use – Commonly used for respiratory, urinary tract, skin and soft tissue, bone and joint, intra-abdominal, and gynecological infections.
IM/IV Administration – Suitable for both intramuscular and intravenous administration under medical supervision.